$COR
Cencora, Inc. Stock $cor

$cor Overview Financials Valuation SEC Filings Company Website

2014 Q3 Form 10-K Financial Statement

#000104746914009555 Filed on November 25, 2014

Income Statement

Concept	2014 Q3	2014 Q2	2014 Q1
Revenue	$31.59B	$30.35B	$28.46B
YoY Change	29.1%	38.53%	38.65%
Cost Of Revenue	$30.72B	$29.66B	$27.73B
YoY Change	28.51%	38.94%	39.98%
Gross Profit	$872.5M	$692.0M	$729.6M
YoY Change	53.74%	23.03%	1.76%
Gross Profit Margin	2.76%	2.28%	2.56%
Selling, General & Admin	$459.2M	$387.6M	$376.3M
YoY Change	28.17%	17.04%	16.32%
% of Gross Profit	52.63%	56.01%	51.58%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$55.40M	$49.20M	$46.30M
YoY Change	25.34%	14.69%	9.98%
% of Gross Profit	6.35%	7.11%	6.35%
Operating Expenses	$459.2M	$387.6M	$376.3M
YoY Change	28.17%	17.04%	16.32%
Operating Profit	$207.3M	$110.9M	$301.1M
YoY Change	81.51%	-17.65%	-13.99%
Interest Expense	-$24.00M	-$21.00M	-$19.47M
YoY Change	26.32%	16.67%	5.21%
% of Operating Profit	-11.58%	-18.94%	-6.47%
Other Income/Expense, Net	-$1.332M	$1.312M	$3.783M
YoY Change	-210.36%	-349.9%	-605.07%
Pretax Income	$188.3M	$58.33M	$285.4M
YoY Change	94.65%	-49.68%	-13.73%
Income Tax	$120.5M	$71.11M	$105.4M
% Of Pretax Income	63.99%	121.91%	36.91%
Net Earnings	$67.80M	-$12.78M	$180.1M
YoY Change	32.89%	-107.59%	294.61%
Net Earnings / Revenue	0.21%	-0.04%	0.63%
Basic Earnings Per Share	$0.30	-$0.06	$0.78
Diluted Earnings Per Share	$0.29	-$0.06	$0.76
COMMON SHARES
Basic Shares Outstanding			229.4M shares
Diluted Shares Outstanding			236.3M shares

Balance Sheet

Concept	2014 Q3	2014 Q2	2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.809B	$1.262B	$697.0M
YoY Change	46.95%	-19.52%	-48.26%
Cash & Equivalents	$1.809B	$1.262B	$697.0M
Short-Term Investments
Other Short-Term Assets	$85.00M	$74.00M	$64.00M
YoY Change	-34.23%	-18.68%	-88.04%
Inventory	$8.594B	$8.422B	$8.493B
Prepaid Expenses
Receivables	$6.313B	$6.133B	$6.506B
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$16.80B	$15.89B	$15.76B
YoY Change	16.72%	30.91%	34.41%
LONG-TERM ASSETS
Property, Plant & Equipment	$899.6M	$882.0M	$851.0M
YoY Change	11.95%	13.5%	11.68%
Goodwill	$2.949B	$2.950B	$2.949B
YoY Change	0.12%	0.18%	0.14%
Intangibles	$533.2M	$539.4M	$545.9M
YoY Change	-3.88%	-3.73%	-3.68%
Long-Term Investments
YoY Change
Other Assets	$350.7M	$368.0M	$255.2M
YoY Change	58.16%	132.37%	127.05%
Total Long-Term Assets	$4.732B	$4.740B	$4.601B
YoY Change	4.57%	6.75%	4.9%
TOTAL ASSETS
Total Short-Term Assets	$16.80B	$15.89B	$15.76B
Total Long-Term Assets	$4.732B	$4.740B	$4.601B
Total Assets	$21.53B	$20.63B	$20.36B
YoY Change	13.81%	24.44%	26.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$15.59B	$14.81B	$14.91B
YoY Change	16.92%	34.52%	43.88%
Accrued Expenses	$561.9M	$471.0M	$587.2M
YoY Change	5.5%	6.8%	26.8%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$17.25B	$16.34B	$16.50B
YoY Change	16.0%	31.33%	37.01%
LONG-TERM LIABILITIES
Long-Term Debt	$1.996B	$1.995B	$1.397B
YoY Change	42.89%	42.86%	0.05%
Other Long-Term Liabilities	$329.5M	$309.0M	$318.9M
YoY Change	-0.65%	-4.35%	-2.26%
Total Long-Term Liabilities	$2.325B	$2.304B	$318.9M
YoY Change	34.54%	33.99%	-81.49%
TOTAL LIABILITIES
Total Short-Term Liabilities	$17.25B	$16.34B	$16.50B
Total Long-Term Liabilities	$2.325B	$2.304B	$318.9M
Total Liabilities	$19.58B	$18.64B	$16.82B
YoY Change	17.93%	31.66%	22.18%
SHAREHOLDERS EQUITY
Retained Earnings	$1.570B		$1.621B
YoY Change	4.11%		16.95%
Common Stock	$2.752B		$2.362B
YoY Change	16.42%		1.23%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$2.313B		$1.793B
YoY Change	52.51%		36.15%
Treasury Stock Shares	49.22M shares		41.95M shares
Shareholders Equity	$1.943B	$1.986B	$2.146B
YoY Change
Total Liabilities & Shareholders Equity	$21.53B	$20.63B	$20.36B
YoY Change	13.81%	24.44%	26.38%

Cashflow Statement

Concept	2014 Q3	2014 Q2	2014 Q1
OPERATING ACTIVITIES
Net Income	$67.80M	-$12.78M	$180.1M
YoY Change	32.89%	-107.59%	294.61%
Depreciation, Depletion And Amortization	$55.40M	$49.20M	$46.30M
YoY Change	25.34%	14.69%	9.98%
Cash From Operating Activities	$832.2M	$519.8M	$1.116B
YoY Change	-2784.52%	589.39%	13.28%
INVESTING ACTIVITIES
Capital Expenditures	-$65.80M	-$73.30M	-$66.20M
YoY Change	1.86%	48.08%	106.23%
Acquisitions
YoY Change
Other Investing Activities	$800.0K	-$117.8M	$6.300M
YoY Change	-200.0%	-135.69%	-240.0%
Cash From Investing Activities	-$65.00M	-$191.1M	-$59.90M
YoY Change	-0.46%	-168.13%	64.11%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-220.6M	236.4M	-707.1M
YoY Change	-8.24%	-274.34%	3641.27%
NET CHANGE
Cash From Operating Activities	832.2M	519.8M	1.116B
Cash From Investing Activities	-65.00M	-191.1M	-59.90M
Cash From Financing Activities	-220.6M	236.4M	-707.1M
Net Change In Cash	546.6M	565.1M	349.3M
YoY Change	-262.34%	156.51%	-62.44%
FREE CASH FLOW
Cash From Operating Activities	$832.2M	$519.8M	$1.116B
Capital Expenditures	-$65.80M	-$73.30M	-$66.20M
Free Cash Flow	$898.0M	$593.1M	$1.183B
YoY Change	2572.62%	374.86%	16.22%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1995632000	USD
CY2013Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6051920000	USD
CY2013Q3	us-gaap	Other Assets Current OtherAssetsCurrent	129231000	USD
CY2013Q3	us-gaap	Assets Current AssetsCurrent	14393651000	USD
CY2013Q3	us-gaap	Land Land	37538000	USD
CY2013Q3	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	324150000	USD
CY2013Q3	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	1109731000	USD
CY2014Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	329492000	USD
CY2014Q3	us-gaap	Common Stock Value CommonStockValue	2711000	USD
CY2014Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2749185000	USD
CY2014Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1570429000	USD
CY2014Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-52046000	USD
CY2014Q3	us-gaap	Treasury Stock Value TreasuryStockValue	2313380000	USD
CY2014Q3	us-gaap	Stockholders Equity StockholdersEquity	1956899000	USD
CY2014Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21532183000	USD
CY2013Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1231006000	USD
CY2013Q3	us-gaap	Inventory Net InventoryNet	6981494000	USD
CY2014Q3	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	2056600000	USD
CY2013Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1471419000	USD
CY2013Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	667858000	USD
CY2013Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	803561000	USD
CY2013Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	221713000	USD
CY2013Q3	us-gaap	Assets Assets	18918638000	USD
CY2013Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	13335792000	USD
CY2013Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	532564000	USD
CY2013Q3	us-gaap	Deferred Tax Liabilities Current DeferredTaxLiabilitiesCurrent	1002279000	USD
CY2013Q3	us-gaap	Liabilities Current LiabilitiesCurrent	14870635000	USD
CY2013Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1396606000	USD
CY2013Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	331652000	USD
CY2013Q3	us-gaap	Common Stock Value CommonStockValue	2678000	USD
CY2013Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2360992000	USD
CY2013Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1508414000	USD
CY2013Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-35483000	USD
CY2013Q3	us-gaap	Treasury Stock Value TreasuryStockValue	1516856000	USD
CY2013Q3	us-gaap	Stockholders Equity StockholdersEquity	2319745000	USD
CY2013Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18918638000	USD
CY2014Q3	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	3481744000	USD
CY2013Q3	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	3499713000	USD
CY2014Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2014Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	49218103	shares
CY2013Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2013Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	673428000	USD
CY2014	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	389398000	USD
CY2014	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	284030000	USD
CY2014	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-7546000	USD
CY2014	us-gaap	Net Income Loss NetIncomeLoss	276484000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.25
CY2014	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.03
CY2014	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.22
CY2014	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.21
CY2014	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.03
CY2014	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.17
CY2014	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	227367000	shares
CY2014	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	235405000	shares
CY2013	us-gaap	Revenues Revenues	87959167000	USD
CY2013	us-gaap	Cost Of Goods Sold CostOfGoodsSold	85451348000	USD
CY2013	us-gaap	Gross Profit GrossProfit	2507819000	USD
CY2013	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1333712000	USD
CY2013	us-gaap	Depreciation Nonproduction DepreciationNonproduction	135047000	USD
CY2013	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	27139000	USD
CY2013	us-gaap	Restructuring Charges RestructuringCharges	23467000	USD
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	898399000	USD
CY2013	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-44000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	824458000	USD
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	331023000	USD
CY2013	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	493435000	USD
CY2013	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-59728000	USD
CY2013	us-gaap	Net Income Loss NetIncomeLoss	433707000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	2.14
CY2013	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.26
CY2012	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	252906000	shares
CY2012	us-gaap	Revenues Revenues	78080806000	USD
CY2013	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.88
CY2013	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	2.10
CY2013	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.25
CY2013	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.84
CY2013	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	231067000	shares
CY2013	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	235345000	shares
CY2012	us-gaap	Cost Of Goods Sold CostOfGoodsSold	75446120000	USD
CY2012	us-gaap	Gross Profit GrossProfit	2634686000	USD
CY2012	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1152556000	USD
CY2012	us-gaap	Depreciation Nonproduction DepreciationNonproduction	112828000	USD
CY2012	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	21547000	USD
CY2012	us-gaap	Restructuring Charges RestructuringCharges	44140000	USD
CY2012	us-gaap	Operating Income Loss OperatingIncomeLoss	1303615000	USD
CY2012	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	5827000	USD
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1216873000	USD
CY2012	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	455512000	USD
CY2012	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	761361000	USD
CY2012	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-42375000	USD
CY2012	us-gaap	Net Income Loss NetIncomeLoss	718986000	USD
CY2012	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	3.01
CY2012	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.17
CY2012	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.84
CY2012	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	2.96
CY2012	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.16
CY2012	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.80
CY2012	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	256903000	shares
CY2014	abc	Diluted Rounding DilutedRounding	-0.01
CY2013	abc	Diluted Rounding DilutedRounding	-0.01
CY2012	abc	Diluted Rounding DilutedRounding	0
CY2014	us-gaap	Other General Expense OtherGeneralExpense	422739000	USD
CY2013	us-gaap	Other General Expense OtherGeneralExpense	90055000	USD
CY2012	us-gaap	Other General Expense OtherGeneralExpense	0	USD
CY2014	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-76862000	USD
CY2013	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-73897000	USD
CY2012	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-92569000	USD
CY2014	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-32954000	USD
CY2013	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2012	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2014	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	0	USD
CY2013	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	9638000	USD
CY2012	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	4841000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-18544000	USD
CY2014	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	-419000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-16563000	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	259921000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-11216000	USD
CY2012	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-1538000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-2400000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	1361000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	7992000	USD
CY2012	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	1096000	USD
CY2014	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.94
CY2014	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	26634000	USD
CY2014	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	39312000	USD
CY2014	us-gaap	Share Based Compensation ShareBasedCompensation	43107000	USD
CY2014	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	6539000	USD
CY2014	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	938286000	USD
CY2014	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	956506000	USD
CY2014	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-21107000	USD
CY2014	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2317589000	USD
CY2014	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-8175000	USD
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	1470699000	USD
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1463153000	USD
CY2014	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	264457000	USD
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-384155000	USD
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-384155000	USD
CY2014	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	1097927000	USD
CY2014	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	531525000	USD
CY2014	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	17584500000	USD
CY2014	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	17584500000	USD
CY2014	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	753926000	USD
CY2014	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	127906000	USD
CY2014	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	214469000	USD
CY2014	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-16007000	USD
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-501491000	USD
CY2014	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	577507000	USD
CY2013	us-gaap	Depreciation Depreciation	138690000	USD
CY2013	us-gaap	Adjustment For Amortization AdjustmentForAmortization	32103000	USD
CY2013	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	20118000	USD
CY2013	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	25573000	USD
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	36275000	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	128932000	USD
CY2013	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	-11672000	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	117260000	USD
CY2013	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	2330000000	USD
CY2013	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	2330000000	USD
CY2013	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	484176000	USD
CY2013	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	155713000	USD
CY2013	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	195716000	USD
CY2013	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-8975000	USD
CY2012	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	-39010000	USD
CY2012	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-947949000	USD
CY2012	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	60500000	USD
CY2012	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	60500000	USD
CY2012	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1162246000	USD
CY2012	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	115224000	USD
CY2012	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	132760000	USD
CY2012	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-10658000	USD
CY2012	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1116882000	USD
CY2012	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-759382000	USD
CY2011Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1825990000	USD
CY2013	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-740987000	USD
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	164398000	USD
CY2012Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1066608000	USD
CY2012	us-gaap	Depreciation Depreciation	113765000	USD
CY2012	us-gaap	Adjustment For Amortization AdjustmentForAmortization	26750000	USD
CY2012	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	23058000	USD
CY2012	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	61278000	USD
CY2012	us-gaap	Share Based Compensation ShareBasedCompensation	25954000	USD
CY2012	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	9184000	USD
CY2012	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-71510000	USD
CY2012	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	116174000	USD
CY2012	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-49716000	USD
CY2012	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	416100000	USD
CY2012	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-7177000	USD
CY2012	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	1416957000	USD
CY2012	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-111508000	USD
CY2012	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1305449000	USD
CY2012	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	133292000	USD
CY2012	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	775670000	USD
CY2012	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-908939000	USD
CY2013	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2014	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	9103000	USD
CY2014	us-gaap	Depreciation Depreciation	162089000	USD
CY2014	us-gaap	Adjustment For Amortization AdjustmentForAmortization	30644000	USD
CY2014	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-7546000	USD
CY2014	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	0	USD
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-501491000	USD
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-690449000	USD
CY2012	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-1138476000	USD
CY2012	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	21594000	USD
CY2013	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	-50538000	USD
CY2014	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	0	USD
CY2012	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	447326000	USD
CY2014	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	422739000	USD
CY2013	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	90055000	USD
CY2012	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	0	USD
CY2014	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	USD
CY2013	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	329980000	USD
CY2012	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	USD
CY2014	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	211397000	USD
CY2013	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	157295000	USD
CY2012	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	0	USD
CY2014	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	117794000	USD
CY2013	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	USD
CY2012	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	USD
CY2014	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-7199000	USD
CY2013	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-1402000	USD
CY2012	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-23000	USD
CY2014	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	46341000	USD
CY2014	us-gaap	Nature Of Operations NatureOfOperations	<p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:11px;">AmerisourceBergen Corporation (the “Company”) </font><font style="font-family:Times New Roman;font-size:10pt;">is one of the </font><font style="font-family:Times New Roman;font-size:10pt;">largest </font><font style="font-family:Times New Roman;font-size:10pt;">global </font><font style="font-family:Times New Roman;font-size:10pt;">pharmaceutical </font><font style="font-family:Times New Roman;font-size:10pt;">sourcing and distribution </font><font style="font-family:Times New Roman;font-size:10pt;">services companies</font><font style="font-family:Times New Roman;font-size:10pt;">, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The Company delivers innovative programs and services designed to increase the effectiveness and efficiency of the pharmaceutical supply chain</font><font style="font-family:Times New Roman;font-size:10pt;">. </font></p><p style='margin-top:0pt; margin-bottom:0pt'> </p>
CY2014	us-gaap	Use Of Estimates UseOfEstimates	<p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:11px;">The preparation of financial statements in conformity with </font><font style="font-family:Times New Roman;font-size:10pt;">U.S. generally </font><font style="font-family:Times New Roman;font-size:10pt;">accounting principles requires management to make estimates and assumptions that affect amounts reported in the financial statements and accompanying notes. Actual amounts could differ from these estimated amounts</font><font style="font-family:Times New Roman;font-size:10pt;"> due to uncertainties inherent in such estimates</font><font style="font-family:Times New Roman;font-size:10pt;">.</font><font style="font-family:Times New Roman;font-size:10pt;"> Management periodically evaluates estimates used in the preparation of the financial statements for continued reasonableness.</font></p><p style='margin-top:0pt; margin-bottom:0pt'> </p>
CY2014	us-gaap	Reclassifications Reclassifications	<p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:11px;">Effective October 1, 2013, the Company transitioned the financial reporting of its Canadian business from the Pharmaceutical Distribution reportable segment to </font><font style="font-family:Times New Roman;font-size:10pt;">Other</font><font style="font-family:Times New Roman;font-size:10pt;">. As a result, </font><font style="font-family:Times New Roman;font-size:10pt;">reclassifi</font><font style="font-family:Times New Roman;font-size:10pt;">cations have been made to prior </font><font style="font-family:Times New Roman;font-size:10pt;">year amounts in </font><font style="font-family:Times New Roman;font-size:10pt;">order to conform to the current </font><font style="font-family:Times New Roman;font-size:10pt;">year presentation.</font></p><p style='margin-top:0pt; margin-bottom:0pt'> </p>
CY2012	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	25703000	USD
CY2014Q3	us-gaap	Percentage Of Lifo Inventory PercentageOfLIFOInventory	0.84	pure
CY2013Q3	us-gaap	Percentage Of Lifo Inventory PercentageOfLIFOInventory	0.83	pure
CY2014Q3	us-gaap	Excess Of Replacement Or Current Costs Over Stated Lifo Value ExcessOfReplacementOrCurrentCostsOverStatedLIFOValue	881800000	USD
CY2013Q3	us-gaap	Excess Of Replacement Or Current Costs Over Stated Lifo Value ExcessOfReplacementOrCurrentCostsOverStatedLIFOValue	533700000	USD
CY2014Q3	abc	Accrual For Estimated Customer Sales Returns AccrualForEstimatedCustomerSalesReturns	932600000	USD
CY2013Q3	abc	Accrual For Estimated Customer Sales Returns AccrualForEstimatedCustomerSalesReturns	275800000	USD
CY2014	us-gaap	Shipping Handling And Transportation Costs ShippingHandlingAndTransportationCosts	348300000	USD
CY2013	us-gaap	Shipping Handling And Transportation Costs ShippingHandlingAndTransportationCosts	267300000	USD
CY2012	us-gaap	Shipping Handling And Transportation Costs ShippingHandlingAndTransportationCosts	259100000	USD
CY2014Q3	us-gaap	Derivative Number Of Instruments Held DerivativeNumberOfInstrumentsHeld	1	pure
CY2013Q3	us-gaap	Derivative Number Of Instruments Held DerivativeNumberOfInstrumentsHeld	1	pure
CY2013Q3	abc	Discontinued Operations Note Due From Buyer1 DiscontinuedOperationsNoteDueFromBuyer1	50000000	CAD
CY2014	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	0	USD
CY2013	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	1181231000	USD
CY2012	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	1639684000	USD
CY2014	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	-7546000	USD
CY2013	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	-50090000	USD
CY2012	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	-37534000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax	9300000	USD
CY2014	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	15733000	USD
CY2013	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	8391000	USD
CY2012	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	4953000	USD
CY2014	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	350086000	USD
CY2013	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	305450000	USD
CY2012	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	394234000	USD
CY2014	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	16576000	USD
CY2013	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	29189000	USD
CY2012	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	47348000	USD
CY2014	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	22842000	USD
CY2013	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-3375000	USD
CY2012	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	11959000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	591909000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	81519000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	793137000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	31321000	USD
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	1193047000	USD
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	23826000	USD
CY2014	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	297052000	USD
CY2013	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	259457000	USD
CY2012	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	356843000	USD
CY2014	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	37301000	USD
CY2013	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	37602000	USD
CY2012	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	32438000	USD
CY2014	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-106000	USD
CY2013	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-241000	USD
CY2012	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	1971000	USD
CY2014	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350	pure
CY2012	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350	pure
CY2014	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.058	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.030	pure
CY2012	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.023	pure
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.005	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.002	pure
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.002	pure
CY2014	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.578	pure
CY2013	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.402	pure
CY2012	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.374	pure
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.019	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.003	pure
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.001	pure
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.184	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.023	pure
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.000	pure
CY2014Q3	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	111525000	USD
CY2013Q3	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	128289000	USD
CY2014Q3	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	273147000	USD
CY2013Q3	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	260357000	USD
CY2014Q3	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	988000	USD
CY2013Q3	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	1322000	USD
CY2014Q3	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1532355000	USD
CY2013Q3	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1406490000	USD
CY2014Q3	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	-61886000	USD
CY2013Q3	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	-297806000	USD
CY2014Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	-33915000	USD
CY2013Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	-30073000	USD
CY2014Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	-23857000	USD
CY2013Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	-16731000	USD
CY2014Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Other DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther	-6534000	USD
CY2013Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Other DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther	-4884000	USD
CY2014Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	-35845000	USD
CY2013Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	-29356000	USD
CY2014Q3	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	-54213000	USD
CY2013Q3	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	-57640000	USD
CY2014Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	-301080000	USD
CY2013Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	-507113000	USD
CY2014Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	105393000	USD
CY2013Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	327546000	USD
CY2014Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	195687000	USD
CY2013Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	179567000	USD
CY2014Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	1336668000	USD
CY2013Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	1226923000	USD
CY2014Q3	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Inventory Costs DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts	1146695000	USD
CY2013Q3	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Inventory Costs DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts	1016522000	USD
CY2014Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	-59404000	USD
CY2013Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	-61726000	USD
CY2014Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	-25426000	USD
CY2013Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	-8897000	USD
CY2012Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	36990000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	5272000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	2825000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	-519000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	-801000	USD
CY2013Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	46267000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	6127000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	1249000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	-4788000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	-1780000	USD
CY2014Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	42908000	USD
CY2011Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	35803000	USD
CY2012	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	6094000	USD
CY2012	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	1045000	USD
CY2012	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	-5177000	USD
CY2012	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	-2286000	USD
CY2012	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	-1237000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Increases Resulting From Acquisition UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition	2500000	USD
CY2012	us-gaap	Unrecognized Tax Benefits Increases Resulting From Acquisition UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition	2748000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	-4167000	USD
CY2014Q3	abc	Potential Tax Benefits From Foreign Net Operating Loss Carryforwards PotentialTaxBenefitsFromForeignNetOperatingLossCarryforwards	6400000	USD
CY2014Q3	abc	Potentaial Tax Benefits From Federal Net Operating Loss Carryforwards PotentaialTaxBenefitsFromFederalNetOperatingLossCarryforwards	7600000	USD
CY2014Q3	abc	Potential Tax Benefits From State Net Operating Loss Carryforwards PotentialTaxBenefitsFromStateNetOperatingLossCarryforwards	69700000	USD
CY2014Q3	abc	Potential Tax Benefits From Capital Loss Carryforwards PotentialTaxBenefitsFromCapitalLossCarryforwards	61900000	USD
CY2014Q3	abc	State Tax Credit Carryforwards StateTaxCreditCarryforwards	1400000	USD
CY2014	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	197000000	USD
CY2013	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	313700000	USD
CY2012	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	302100000	USD
CY2014Q3	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	7700000	USD
CY2013Q3	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	9100000	USD
CY2014Q3	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	35800000	USD
CY2013Q3	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	39100000	USD
CY2014Q3	us-gaap	Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit	6900000	USD
CY2014Q3	abc	Unrecognized Tax Benefits Including Federal Benefit UnrecognizedTaxBenefitsIncludingFederalBenefit	50600000	USD
CY2013Q3	abc	Unrecognized Tax Benefits Including Federal Benefit UnrecognizedTaxBenefitsIncludingFederalBenefit	55400000	USD
CY2014Q3	abc	Potential Tax Benefits That Would Be Recorded As Paid In Capital PotentialTaxBenefitsThatWouldBeRecordedAsPaidInCapital	13200000	USD
CY2014Q3	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	217000000	USD
CY2014Q3	abc	Foreign Tax Credit Carryforward ForeignTaxCreditCarryforward	5800000	USD
CY2013Q1	abc	Full Value Of Warrants FullValueOfWarrants	242400000	USD
CY2013	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	73400000	USD
CY2014Q3	abc	Alternative Minimum Tax Credit Carryforwards AlternativeMinimumTaxCreditCarryforwards	2400000	USD
CY2014	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-222200000	USD
CY2012Q3	us-gaap	Goodwill Goodwill	2942984000	USD
CY2013	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	3000000	USD
CY2013	us-gaap	Goodwill Translation Adjustments GoodwillTranslationAdjustments	-1014000	USD
CY2013Q3	us-gaap	Goodwill Goodwill	2944970000	USD
CY2014	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	5665000	USD
CY2014	us-gaap	Goodwill Translation Adjustments GoodwillTranslationAdjustments	-2133000	USD
CY2014Q3	us-gaap	Goodwill Goodwill	2948502000	USD
CY2014Q3	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	343707000	USD
CY2013Q3	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	343892000	USD
CY2014Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	533242000	USD
CY2013Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	554743000	USD
CY2013Q3	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	679052000	USD
CY2013Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-124309000	USD
CY2014Q3	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	683029000	USD
CY2014Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-149787000	USD
CY2014Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	22400000	USD
CY2014Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	21600000	USD
CY2014Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	17800000	USD
CY2014Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	15400000	USD
CY2014Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	14800000	USD
CY2014Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	97500000	USD
CY2014Q3	us-gaap	Long Term Debt LongTermDebt	1995632000	USD
CY2013Q3	us-gaap	Long Term Debt LongTermDebt	1396606000	USD
CY2014	us-gaap	Interest Paid InterestPaid	62900000	USD
CY2013	us-gaap	Interest Paid InterestPaid	68500000	USD
CY2012	us-gaap	Interest Paid InterestPaid	84500000	USD
CY2014	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts	3900000	USD
CY2013	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts	4200000	USD
CY2012	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts	5200000	USD
CY2014Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	600000000	USD
CY2014Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	1400000000	USD
CY2014Q3	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	-32212000	USD
CY2013Q3	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	-34612000	USD
CY2014Q3	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-19388000	USD
CY2013Q3	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-844000	USD
CY2014Q3	abc	Accumulated Other Comprehensive Income Loss Other Net Of Tax AccumulatedOtherComprehensiveIncomeLossOtherNetOfTax	-446000	USD
CY2013Q3	abc	Accumulated Other Comprehensive Income Loss Other Net Of Tax AccumulatedOtherComprehensiveIncomeLossOtherNetOfTax	-27000	USD
CY2014	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	4787000	shares
CY2013	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	4278000	shares
CY2012	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	3997000	shares
CY2012Q3	abc	Accelerated Share Repurchase Program Initial Funding Allocated To Fees AcceleratedShareRepurchaseProgramInitialFundingAllocatedToFees	800000	USD
CY2012Q4	abc	Accelerated Share Repurchase Program Authorized Amount AcceleratedShareRepurchaseProgramAuthorizedAmount	250000000	USD
CY2012Q4	abc	Accelerated Stock Repurchase Program Initial Delivery Of Shares AcceleratedStockRepurchaseProgramInitialDeliveryOfShares	6200000	shares
CY2012Q4	abc	Accelerated Share Repurchase Program Initial Funding Allocated To Share Purchases AcceleratedShareRepurchaseProgramInitialFundingAllocatedToSharePurchases	248500000	USD
CY2014	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	3251000	shares
CY2013	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2012	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2014Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2014Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2014	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2000000	shares
CY2013	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2012	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2100000	shares
CY2012Q3	abc	Accelerated Share Repurchase Program Authorized Amount AcceleratedShareRepurchaseProgramAuthorizedAmount	650000000	USD
CY2012Q3	abc	Accelerated Stock Repurchase Program Initial Delivery Of Shares AcceleratedStockRepurchaseProgramInitialDeliveryOfShares	16800000	shares
CY2012Q3	abc	Accelerated Share Repurchase Program Initial Funding Allocated To Share Purchases AcceleratedShareRepurchaseProgramInitialFundingAllocatedToSharePurchases	647200000	USD
CY2012Q3	abc	Accelerated Share Repurchase Program Initial Funding Allocated To Prepaid Dividends AcceleratedShareRepurchaseProgramInitialFundingAllocatedToPrepaidDividends	2000000	USD
CY2012Q4	abc	Accelerated Share Repurchase Program Incremental Shares Received Upon Settlement AcceleratedShareRepurchaseProgramIncrementalSharesReceivedUponSettlement	100000	shares
CY2012Q4	abc	Accelerated Share Repurchase Program Initial Funding Allocated To Prepaid Dividends AcceleratedShareRepurchaseProgramInitialFundingAllocatedToPrepaidDividends	1300000	USD
CY2012Q4	abc	Accelerated Share Repurchase Program Initial Funding Allocated To Fees AcceleratedShareRepurchaseProgramInitialFundingAllocatedToFees	200000	USD
CY2013Q1	abc	Shares To Which Framework Agreement Allows Open Market Purchases SharesToWhichFrameworkAgreementAllowsOpenMarketPurchases	19859795	shares
CY2013Q1	abc	Percentage Of Common Stock Purchases In Open Market Granted Under Framework Agreement PercentageOfCommonStockPurchasesInOpenMarketGrantedUnderFrameworkAgreement	0.07	pure
CY2014Q3	abc	Fair Value Per Share Of First Tranche Of Warrants FairValuePerShareOfFirstTrancheOfWarrants	25.20
CY2014Q3	abc	Fair Value Per Share Of Second Tranche Of Warrants FairValuePerShareOfSecondTrancheOfWarrants	25.02
CY2014Q3	abc	Full Value Of Warrants FullValueOfWarrants	1139800000	USD
CY2014	abc	Percentage Of Warrant Dilution Intended To Be Hedged With Contract PercentageOfWarrantDilutionIntendedToBeHedgedWithContract	0.60	pure
CY2013Q3	abc	Shares Covered Under Derivative Purchases SharesCoveredUnderDerivativePurchases	15300000	shares
CY2013	us-gaap	Derivative Cost Of Hedge DerivativeCostOfHedge	163400000	USD
CY2014Q3	abc	Shares Covered Under Derivative Purchases SharesCoveredUnderDerivativePurchases	11900000	shares
CY2014	us-gaap	Derivative Cost Of Hedge DerivativeCostOfHedge	205300000	USD
CY2012Q4	us-gaap	Accelerated Share Repurchase Program Adjustment AcceleratedShareRepurchaseProgramAdjustment	10300000	USD
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	6.36
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	131800000	USD
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	82100000	USD
CY2014Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	338300000	USD
CY2014Q3	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	58200000	USD
CY2014Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	54400000	USD
CY2014Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	44700000	USD
CY2014Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	41200000	USD
CY2014Q3	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	34200000	USD
CY2014	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	81800000	USD
CY2013	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	79600000	USD
CY2012	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	65300000	USD
CY2014Q3	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	105600000	USD
CY2015Q3	abc	Remaining Purchase Commitment For Ibm Global Services Current RemainingPurchaseCommitmentForIbmGlobalServicesCurrent	37100000	USD
CY2014Q3	abc	Remaining Purchase Commitment Estimate For Ibm Global Services RemainingPurchaseCommitmentEstimateForIbmGlobalServices	74100000	USD
CY2014Q3	abc	Remaining Purchase Commitment Estimate For Flu Vaccine RemainingPurchaseCommitmentEstimateForFluVaccine	72900000	USD
CY2014	us-gaap	Other Restructuring Costs OtherRestructuringCosts	1913000	USD
CY2013	us-gaap	Other Restructuring Costs OtherRestructuringCosts	491000	USD
CY2012	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	11100000	USD
CY2014Q3	abc	Retirement Benefit Plans Net Actuarial Loss Included In Accumulated Other Comprehensive Income Gross RetirementBenefitPlansNetActuarialLossIncludedInAccumulatedOtherComprehensiveIncomeGross	55500000	USD
CY2014Q3	abc	Retirement Benefit Plans Net Actuarial Loss Included In Accumulated Other Comprehensive Loss Net Of Tax RetirementBenefitPlansNetActuarialLossIncludedInAccumulatedOtherComprehensiveLossNetOfTax	32200000	USD
CY2014	abc	Retirement Benefit Plans Net Actuarial Loss Expected Amortization Gross RetirementBenefitPlansNetActuarialLossExpectedAmortizationGross	4100000	USD
CY2014	abc	Retirement Benefit Plans Expected Net Actuarial Loss Amortization Net Of Tax RetirementBenefitPlansExpectedNetActuarialLossAmortizationNetOfTax	2400000	USD
CY2014Q3	us-gaap	Deferred Compensation Arrangement With Individual Recorded Liability DeferredCompensationArrangementWithIndividualRecordedLiability	16200000	USD
CY2013Q3	us-gaap	Deferred Compensation Arrangement With Individual Recorded Liability DeferredCompensationArrangementWithIndividualRecordedLiability	13300000	USD
CY2014	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	22500000	USD
CY2013	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	17400000	USD
CY2012	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	16400000	USD
CY2014	us-gaap	Pension And Other Postretirement Benefit Expense PensionAndOtherPostretirementBenefitExpense	27900000	USD
CY2013	us-gaap	Pension And Other Postretirement Benefit Expense PensionAndOtherPostretirementBenefitExpense	22100000	USD
CY2012	us-gaap	Pension And Other Postretirement Benefit Expense PensionAndOtherPostretirementBenefitExpense	20300000	USD
CY2014Q3	us-gaap	Deferred Compensation Arrangement With Individual Shares Authorized For Issuance DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance	2960000	shares
CY2014Q3	abc	Defined Benefit Plan Number Of Plan Participants DefinedBenefitPlanNumberOfPlanParticipants	3200	pure
CY2014Q3	abc	Defined Benefit Plan Number Of Active Employees DefinedBenefitPlanNumberOfActiveEmployees	500	pure
CY2014	abc	Option Award Fair Value Assumptions Expected Term OptionAwardFairValueAssumptionsExpectedTerm	3.69 years
CY2013	abc	Option Award Fair Value Assumptions Expected Term OptionAwardFairValueAssumptionsExpectedTerm	3.69 years
CY2012	abc	Option Award Fair Value Assumptions Expected Term OptionAwardFairValueAssumptionsExpectedTerm	3.69 years
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0089	pure
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0044	pure
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0059	pure
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0137	pure
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0129	pure
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0139	pure
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.2391	pure
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.2422	pure
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.2563	pure
CY2013Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	14119000	shares
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	2332000	shares
CY2014	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	-3059000	shares
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	-272000	shares
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	13120000	shares
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	6319000	shares
CY2014Q3	abc	Options Expected To Vest OptionsExpectedToVest	6303000	shares
CY2013Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	33
CY2013Q3	abc	Distribution Selling And Administrative Expenses Depreciation And Amortization DistributionSellingAndAdministrativeExpensesDepreciationAndAmortization	400799000	USD
CY2013Q3	abc	Share Based Compensation Arrangement By Share Based Payment Award Target Performance Shares Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPerformanceSharesNonvestedNumber	210000	shares
CY2014	abc	Share Based Compensation Arrangement By Share Based Payment Award Target Performance Shares Granted In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPerformanceSharesGrantedInPeriod	95000	shares
CY2013Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	114190000	USD
CY2013Q3	us-gaap	Net Income Loss NetIncomeLoss	51023000	USD
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	46
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	40
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	30
CY2014Q3	abc	Options Expected To Vest Weighted Average Exercise Price OptionsExpectedToVestWeightedAverageExercisePrice	49
CY2013	abc	Weighted Average Contractual Term Options Outstanding WeightedAverageContractualTermOptionsOutstanding	4 years
CY2014	abc	Weighted Average Contractual Term Options Outstanding WeightedAverageContractualTermOptionsOutstanding	4 years
CY2014	abc	Weighted Average Contractual Term Options Exercisable WeightedAverageContractualTermOptionsExercisable	3 years
CY2014	abc	Weighted Average Contractual Term Options Expected To Vest WeightedAverageContractualTermOptionsExpectedToVest	5 years
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	488591000	USD
CY2014Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	296386000	USD
CY2014	abc	Options Expected To Vest Intrinsic Value OptionsExpectedToVestIntrinsicValue	178113000	USD
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	68
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	27
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	-262000	shares
CY2013Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	7667000	shares
CY2014Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	6801000	shares
CY2013Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	7
CY2014Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	8
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	8
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	-2936000	shares
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	7
CY2013Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1123000	shares
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	237000	shares
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	-289000	shares
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	-121000	shares
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	950000	shares
CY2013Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	39
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	69
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	36
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	48
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	39
CY2014	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	21500000	USD
CY2013	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	20200000	USD
CY2012	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	15400000	USD
CY2014	abc	Performance Share Expense PerformanceShareExpense	6800000	USD
CY2013	abc	Performance Share Expense PerformanceShareExpense	3700000	USD
CY2014	us-gaap	Restricted Stock Expense RestrictedStockExpense	14700000	USD
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	19100000	USD
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	17400000	USD
CY2012	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	17200000	USD
CY2014Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	37600000	USD
CY2014	abc	Share Based Compensation Arrangement By Share Based Payment Award Target Performance Shares Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPerformanceSharesVestedInPeriod	-85000	shares
CY2014Q3	abc	Share Based Compensation Arrangement By Share Based Payment Award Target Performance Shares Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPerformanceSharesNonvestedNumber	220000	shares
CY2013Q3	abc	Share Based Compensation Arrangement By Share Based Payment Award Target Performance Shares Outstanding Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPerformanceSharesOutstandingWeightedAverageGrantDateFairValue	39
CY2014	abc	Share Based Compensation Arrangement By Share Based Payment Award Target Performance Shares Granted Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPerformanceSharesGrantedWeightedAverageGrantDateFairValue	68
CY2014	abc	Share Based Compensation Arrangement By Share Based Payment Award Target Performance Shares Vested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPerformanceSharesVestedWeightedAverageGrantDateFairValue	37
CY2014Q3	abc	Share Based Compensation Arrangement By Share Based Payment Award Target Performance Shares Outstanding Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardTargetPerformanceSharesOutstandingWeightedAverageGrantDateFairValue	52
CY2014Q3	abc	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Under Amerisourcebergen Equity Incentive Plan ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantUnderAmerisourcebergenEquityIncentivePlan	27900000	shares
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	11.22
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	6.54
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	132400000	USD
CY2014	abc	Weighted Average Period Of Unrecognized Option Compensation WeightedAveragePeriodOfUnrecognizedOptionCompensation	2.2 years
CY2014Q3	abc	Restricted Stock Compensation Not Yet Recognized RestrictedStockCompensationNotYetRecognized	19000000	USD
CY2014	abc	Weighted Average Period Of Unrecognized Restricted Stock Compensation WeightedAveragePeriodOfUnrecognizedRestrictedStockCompensation	1.1 years
CY2014Q3	abc	Espp Shares Authorized EsppSharesAuthorized	4000000	shares
CY2014	abc	Espp Shares Acquired EsppSharesAcquired	68700	shares
CY2013	abc	Espp Shares Acquired EsppSharesAcquired	93813	shares
CY2012	abc	Espp Shares Acquired EsppSharesAcquired	113692	shares
CY2014Q3	abc	Espp Withholdings EsppWithholdings	1200000	USD
CY2013	us-gaap	Restricted Stock Expense RestrictedStockExpense	12100000	USD
CY2012	us-gaap	Restricted Stock Expense RestrictedStockExpense	9000000	USD
CY2012	abc	Performance Share Expense PerformanceShareExpense	1500000	USD
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	10500000	USD
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	9700000	USD
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	6100000	USD
CY2015Q3	abc	Remaining Purchase Commitment Estimate For Flu Vaccine RemainingPurchaseCommitmentEstimateForFluVaccine	57200000	USD
CY2012	us-gaap	Other Restructuring Costs OtherRestructuringCosts	33040000	USD
CY2014	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	6279000	USD
CY2014	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	24436000	USD
CY2013	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	22976000	USD
CY2014	abc	Pension Expense Included Within Restructuring Charges PensionExpenseIncludedWithinRestructuringCharges	10300000	USD
CY2013	abc	Employees Terminated Under Restructuring Activities EmployeesTerminatedUnderRestructuringActivities	314
CY2012	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	706000	USD
CY2013	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	277001000	USD
CY2014	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	348063000	USD
CY2014	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	-23167000	USD
CY2013	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	-24387000	USD
CY2012	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	-18454000	USD
CY2013	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	22883000	USD
CY2012	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	14813000	USD
CY2014	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	185290000	USD
CY2013	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	162186000	USD
CY2012	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	134375000	USD
CY2014	abc	Distribution Of Pharmaceuticals As Historic Percentage Of Total Revenue DistributionOfPharmaceuticalsAsHistoricPercentageOfTotalRevenue	0.95	pure
CY2014Q3	us-gaap	Other Assets Fair Value Disclosure OtherAssetsFairValueDisclosure	400000000	USD
CY2013Q3	us-gaap	Other Assets Fair Value Disclosure OtherAssetsFairValueDisclosure	0	USD
CY2013Q4	us-gaap	Cost Of Goods Sold CostOfGoodsSold	28488137000	USD
CY2013Q3	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	1502000000	USD
CY2013Q4	us-gaap	Revenues Revenues	29176362000	USD
CY2013Q4	us-gaap	Gross Profit GrossProfit	688225000	USD
CY2013Q4	abc	Distribution Selling And Administrative Expenses Depreciation And Amortization DistributionSellingAndAdministrativeExpensesDepreciationAndAmortization	408010000	USD
CY2013Q4	us-gaap	Restructuring Charges RestructuringCharges	4302000	USD
CY2013Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	159616000	USD
CY2013Q4	us-gaap	Net Income Loss NetIncomeLoss	41385000	USD
CY2014Q1	us-gaap	Revenues Revenues	28455903000	USD
CY2014Q1	us-gaap	Restructuring Charges RestructuringCharges	1967000	USD
CY2014Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	301128000	USD
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	180077000	USD
CY2014Q1	abc	Distribution Selling And Administrative Expenses Depreciation And Amortization DistributionSellingAndAdministrativeExpensesDepreciationAndAmortization	420835000	USD
CY2014Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.76
CY2014Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.78
CY2013Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.18
CY2013Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.17
CY2014Q2	us-gaap	Revenues Revenues	30348154000	USD
CY2014Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2014Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2014Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.30
CY2014Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.29
CY2014Q2	us-gaap	Gross Profit GrossProfit	692004000	USD
CY2014Q2	abc	Distribution Selling And Administrative Expenses Depreciation And Amortization DistributionSellingAndAdministrativeExpensesDepreciationAndAmortization	434945000	USD
CY2014Q2	us-gaap	Restructuring Charges RestructuringCharges	1142000	USD
CY2014Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	110877000	USD
CY2014Q2	us-gaap	Net Income Loss NetIncomeLoss	-12780000	USD
CY2014Q3	us-gaap	Revenues Revenues	31588708000	USD
CY2014Q3	us-gaap	Gross Profit GrossProfit	872544000	USD
CY2014Q3	abc	Distribution Selling And Administrative Expenses Depreciation And Amortization DistributionSellingAndAdministrativeExpensesDepreciationAndAmortization	508761000	USD
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	207263000	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	67802000	USD
CY2014	abc	Distribution Selling And Administrative Expenses Depreciation And Amortization DistributionSellingAndAdministrativeExpensesDepreciationAndAmortization	1772551000	USD
CY2014Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	27726310000	USD
CY2014Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	29656150000	USD
CY2014Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	30716164000	USD
CY2013Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	364060000	USD
CY2014Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	376341000	USD
CY2014Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	387611000	USD
CY2014Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	459249000	USD
CY2013Q4	us-gaap	Depreciation Nonproduction DepreciationNonproduction	37319000	USD
CY2014Q1	us-gaap	Depreciation Nonproduction DepreciationNonproduction	37968000	USD
CY2014Q2	us-gaap	Depreciation Nonproduction DepreciationNonproduction	40880000	USD
CY2014Q3	us-gaap	Depreciation Nonproduction DepreciationNonproduction	43161000	USD
CY2013Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6631000	USD
CY2014Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6526000	USD
CY2014Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6454000	USD
CY2014Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6351000	USD
CY2013Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	597000	USD
CY2014Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3783000	USD
CY2014Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1312000	USD
CY2014Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1332000	USD
CY2013Q4	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-18832000	USD
CY2014Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-19474000	USD
CY2014Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-20903000	USD
CY2014Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-17653000	USD
CY2013Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	141381000	USD
CY2014Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	285437000	USD
CY2014Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	58332000	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	188278000	USD
CY2013Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	92450000	USD
CY2014Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	105360000	USD
CY2014Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	71112000	USD
CY2014Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	120476000	USD
CY2014Q3	us-gaap	Restructuring Charges RestructuringCharges	781000	USD
CY2013Q4	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	48931000	USD
CY2014Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	180077000	USD
CY2014Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-12780000	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	67802000	USD
CY2013Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-7546000	USD
CY2014Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	0	USD
CY2014Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	0	USD
CY2014Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	0	USD
CY2013Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.21
CY2014Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.78
CY2014Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.06
CY2014Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.30
CY2013Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.21
CY2014Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.76
CY2014Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.06
CY2014Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.29
CY2014Q1	us-gaap	Other General Expense OtherGeneralExpense	5663000	USD
CY2014Q2	us-gaap	Other General Expense OtherGeneralExpense	145040000	USD
CY2013Q4	us-gaap	Other General Expense OtherGeneralExpense	116297000	USD
CY2014Q3	us-gaap	Other General Expense OtherGeneralExpense	155739000	USD
CY2013Q4	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2014Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2014Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-32954000	USD
CY2014Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2012Q4	us-gaap	Revenues Revenues	21059811000	USD
CY2012Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.73
CY2012Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.71
CY2013Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.20
CY2013Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.19
CY2013Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.73
CY2013Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.71
CY2013Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.22
CY2013Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.22
CY2012Q4	us-gaap	Gross Profit GrossProfit	660828000	USD
CY2012Q4	abc	Distribution Selling And Administrative Expenses Depreciation And Amortization DistributionSellingAndAdministrativeExpensesDepreciationAndAmortization	359384000	USD
CY2012Q4	us-gaap	Restructuring Charges RestructuringCharges	2004000	USD
CY2012Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	299440000	USD
CY2012Q4	us-gaap	Net Income Loss NetIncomeLoss	168611000	USD
CY2013Q1	us-gaap	Revenues Revenues	20523668000	USD
CY2013Q1	us-gaap	Gross Profit GrossProfit	716989000	USD
CY2013Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	330864000	USD
CY2013Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-749000	USD
CY2013Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-525000	USD
CY2013Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1207000	USD
CY2012Q4	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-18525000	USD
CY2013Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-18510000	USD
CY2013Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-18190000	USD
CY2013Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-18672000	USD
CY2012Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	280938000	USD
CY2013Q1	abc	Distribution Selling And Administrative Expenses Depreciation And Amortization DistributionSellingAndAdministrativeExpensesDepreciationAndAmortization	363404000	USD
CY2013Q1	us-gaap	Restructuring Charges RestructuringCharges	-299000	USD
CY2013Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	350123000	USD
CY2013Q1	us-gaap	Net Income Loss NetIncomeLoss	45634000	USD
CY2013Q2	us-gaap	Revenues Revenues	21906648000	USD
CY2013Q2	us-gaap	Gross Profit GrossProfit	562450000	USD
CY2013Q2	abc	Distribution Selling And Administrative Expenses Depreciation And Amortization DistributionSellingAndAdministrativeExpensesDepreciationAndAmortization	372311000	USD
CY2013Q2	us-gaap	Restructuring Charges RestructuringCharges	19678000	USD
CY2013Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	134646000	USD
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	168439000	USD
CY2013Q3	us-gaap	Revenues Revenues	24469040000	USD
CY2013Q3	us-gaap	Gross Profit GrossProfit	567552000	USD
CY2013Q3	us-gaap	Restructuring Charges RestructuringCharges	2084000	USD
CY2013	abc	Distribution Selling And Administrative Expenses Depreciation And Amortization DistributionSellingAndAdministrativeExpensesDepreciationAndAmortization	1495898000	USD
CY2012Q4	us-gaap	Cost Of Goods Sold CostOfGoodsSold	20398983000	USD
CY2013Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	19806679000	USD
CY2013Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	21344198000	USD
CY2013Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	23901488000	USD
CY2012Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	320700000	USD
CY2013Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	323536000	USD
CY2013Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	331173000	USD
CY2013Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	358303000	USD
CY2012Q4	us-gaap	Depreciation Nonproduction DepreciationNonproduction	31873000	USD
CY2013Q1	us-gaap	Depreciation Nonproduction DepreciationNonproduction	33069000	USD
CY2013Q2	us-gaap	Depreciation Nonproduction DepreciationNonproduction	34395000	USD
CY2013Q3	us-gaap	Depreciation Nonproduction DepreciationNonproduction	35710000	USD
CY2012Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6811000	USD
CY2013Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6799000	USD
CY2013Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6743000	USD
CY2013Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6786000	USD
CY2012Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	23000	USD
CY2013Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	115931000	USD
CY2013Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	96725000	USD
CY2012Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	106317000	USD
CY2013Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	126721000	USD
CY2013Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	51821000	USD
CY2013Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	46164000	USD
CY2012Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.75
CY2013Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.89
CY2013Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.28
CY2013Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.22
CY2013Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.22
CY2013Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.27
CY2013Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.87
CY2014	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	26634000	USD
CY2012	us-gaap	Valuation Allowances And Reserves Charged To Other Accounts ValuationAllowancesAndReservesChargedToOtherAccounts	0	USD
CY2012Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.74
CY2012Q4	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	174621000	USD
CY2013Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	204143000	USD
CY2013Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	64110000	USD
CY2013Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	50561000	USD
CY2012Q4	us-gaap	Other General Expense OtherGeneralExpense	0	USD
CY2013Q1	us-gaap	Other General Expense OtherGeneralExpense	3761000	USD
CY2013Q2	us-gaap	Other General Expense OtherGeneralExpense	35815000	USD
CY2013Q3	us-gaap	Other General Expense OtherGeneralExpense	50479000	USD
CY2013Q4	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	57600000	USD
CY2014Q1	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	102800000	USD
CY2014Q2	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	133200000	USD
CY2014Q3	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	54400000	USD
CY2012Q4	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	1100000	USD
CY2013Q1	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	-200000	USD
CY2013Q2	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	122100000	USD
CY2013Q3	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	154000000	USD
CY2013Q4	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	21000000	USD
CY2014Q1	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	800000	USD
CY2014Q2	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	2500000	USD
CY2012Q4	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	12300000	USD
CY2013Q1	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	3500000	USD
CY2013Q2	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	6000000	USD
CY2013Q3	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	1100000	USD
CY2014Q4	abc	Dividend Increase Percentage DividendIncreasePercentage	0.23	pure
CY2014Q4	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.29
CY2011Q3	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	88833000	USD
CY2012Q3	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	85741000	USD
CY2013Q3	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	82380000	USD
CY2012	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	23058000	USD
CY2013	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	20118000	USD
CY2012	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	-26150000	USD
CY2013	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	-23479000	USD
CY2014	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	-19567000	USD
CY2014Q3	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	89447000	USD
CY2013	us-gaap	Valuation Allowances And Reserves Charged To Other Accounts ValuationAllowancesAndReservesChargedToOtherAccounts	0	USD
CY2014	us-gaap	Valuation Allowances And Reserves Charged To Other Accounts ValuationAllowancesAndReservesChargedToOtherAccounts	0	USD

Files In Submission

Name	View Source	Status
0001047469-14-009555-index-headers.html	Edgar Link	pending
0001047469-14-009555-index.html	Edgar Link	pending
0001047469-14-009555.txt	Edgar Link	pending
R42.htm	Edgar Link	pending
0001047469-14-009555-xbrl.zip	Edgar Link	pending
a2222308z10-k.htm	Edgar Link	pending
a2222308zex-21.htm	Edgar Link	pending
a2222308zex-23.htm	Edgar Link	pending
a2222308zex-31_1.htm	Edgar Link	pending
a2222308zex-31_2.htm	Edgar Link	pending
a2222308zex-32.htm	Edgar Link	pending
abc-20140930.xml	Edgar Link	completed
abc-20140930.xsd	Edgar Link	pending
abc-20140930_cal.xml	Edgar Link	unprocessable
abc-20140930_def.xml	Edgar Link	unprocessable
abc-20140930_lab.xml	Edgar Link	unprocessable
abc-20140930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
g28249.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$COR
Cencora, Inc. Stock $cor

2014 Q3 Form 10-K Financial Statement

#000104746914009555 Filed on November 25, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$COR Cencora, Inc. Stock $cor

2014 Q3 Form 10-K Financial Statement

#000104746914009555 Filed on November 25, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$COR
Cencora, Inc. Stock $cor